1. Clinical outcomes with long-term sorafenib treatment: A multicenter, real-life study. Issue 1 (16th February 2017) Authors: Sacco, R.; Parodi, S.; Zolfino, T.; Saitta, C.; Marzi, L.; Simonetti, N.; Attardo, S.; Rossa, M.; Bresci, G.; Cabibbo, G. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study. (March 2023) Authors: Terracciani, F.; De Vincentis, A.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.09.16 LONG-TERM SORAFENIB TREATMENT IN A LARGE COHORT OF HCC PATIENTS: A MULTICENTER STUDY. Issue 2 (15th March 2018) Authors: Sacco, R.; Granito, A.; Zolfino, T.; Saitta, C.; Marzi, L.; Metrangolo, S.; Parisi, G.; Tumino, E.; Bresci, G.; Cabibbo, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS). (March 2023) Authors: De Vincentis, A.; Terracciani, F.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Role of Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis. (15th February 2015) Authors: Littera, R.; Carcassi, C.; Secci, L.; Lai, S.; Cappai, L.; Porcella, R.; Alba, F.; Maddi, R.; Serra, M.; Cappellini, S.; Salustro, C.; Onali, S.; Balestrieri, C.; Serra, G.; Conti, M.; Zolfino, T.; Scioscia, R.; Barca, L.; Chessa, L. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC). (10th February 2016) Authors: Di Costanzo, G.G.; D'Angelo, S.; Zolfino, T.; Lorusso, V.; Montesarchio, V.; de Stefano, G.; Sacco, R.; Attili, A.F.; Benedetti, A.; Sansonno, D.; Giannitrapani, L.; Buonadonna, A.; Giovanis, P.; Cabibbo, G.; De Vita, F.; Carucci, P.; Pirisi, M.; Moscovici, M.; Pisconti, S.; Daniele, B. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Transient elastography in patients with chronic autoimmune hepatitis: is a good tool in evaluation of hepatic fibrosis?. (15th February 2015) Authors: Onali, S.; Cappellini, S.; Serra, G.; Zolfino, T.; Murgia, D.; Ponti, M.L.; Balestrieri, C.; Conti, M.; Sorbello, O.; Civolani, A.; Casale, M.; Casu, S.; Figorilli, F.; Pasetto, M.C.; Gaspardini, A.; Secci, L.; Salustro, C.; Ganga, R.; Piras, M.R.; Demelia, L. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗